Short communicationIsolation and structural characterization of a new tadalafil analog (2-hydroxyethylnortadalafil) found in a dietary supplement
Graphical abstract
Introduction
It has become increasingly common to detect synthetic, phosphodiesterase type-5 (PDE-5) inhibitors including sildenafil, vardenafil, and tadalafil in products that are labeled as “all-natural” herbal supplements that offer “sexual performance enhancement” [1], [2], [3], [4], [5]. Additionally, many analogs of these PDE-5 inhibitors have been discovered and added to the established screening methods typically run in regulatory agencies [6], [7]. The analogs are structurally similar to their approved correlative drug compounds, displaying minor alterations while retaining the active moiety [8]. The analogs are not declared on the labeling, and little to no information is available regarding their toxicological or pharmacological effects. This presents a substantial risk to public health. As regulatory agencies become more adept at detecting and identifying PDE-5 inhibitor analogs in adulterated dietary supplements, the producers of these supplements are becoming more creative in their synthesis of different compounds to avoid detection. A rapid and quantitative LC–MS/MS screening method for 71 known erectile dysfunction drugs was recently published [9] and new analogs are continuously being discovered in adulterated dietary supplements [10], [11], [12], [13], [14], [15], [16], [17], [18], [19].
This article describes the structural characterization of 2-hydroxyethylnortadalafil (“Compound 1”), an analog of tadalafil (Fig. 1). Compound 1 was detected during a routine screening of a “sexual performance enhancing” dietary supplement using liquid chromatography–ion trap mass spectrometry (LC–MSn). The compound was isolated from the supplement matrix using HPLC-UV coupled to an analytical scale fraction collector. Accurate mass and NMR were performed to fully elucidate the structure of Compound 1.
Section snippets
Sample and chemicals
A dietary supplement product was obtained during an undercover purchase from an online company that listed their manufacturing site as Hong Kong and was submitted to the laboratory for analysis. The product was supplied in a paper board box containing two foil blister packages, each containing six tablets. The product was composited by grinding five tablets to a white powder with a mortar and pestle, placing the ground tablets into a scintillation vial, and using a vortex mixer to thoroughly
HPLC-UV analyses
The isolation of Compound 1 utilized retention time as the trigger for fraction collection, and the peaks were characterized by their UV spectra in comparison to the spectrum obtained from tadalafil. The UV spectrum, compared to that of tadalafil, displayed almost identical characteristics (see Fig. 2).
Based on comparisons of the peak areas to those obtained from tadalafil standard solutions, Compound 1 was present at approximately 34 mg per tablet.
Mass spectrometry
The protonated molecular formula of Compound 1
Conclusion
In the present study, a new tadalafil analog was isolated from a dietary supplement and its structure was elucidated using UV, NMR, and high-resolution MS. The data indicate that the difference in the structure is due to substitution of the N-methyl group on the piperazinedione ring with a CH2CH2OH moiety. The compound was given the name 2-hydroxyethylnortadalafil. To our knowledge, this is the first identification of this analog.
References (19)
- et al.
Analysis of undeclared syntheticphosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC–ESI-MS and LC–UV
J. Pharm. Biomed. Anal.
(2004) - et al.
Simultaneous determination of sildenafil, vardenafil and tadalafil as forbidden components in natural dietary supplements for male sexual potency by high-performance liquid chromatography–electrospray ionization mass spectrometry
J. Chromatogr. A
(2005) - et al.
Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography–electrospray ionization tandem mass spectrometry
J. Chromatogr. A
(2006) - et al.
Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs
Trends Anal. Chem.
(2009) - et al.
Analytical challenges in drug counterfeiting and falsification—the NMR approach
J. Pharm. Biomed. Anal.
(2011) - et al.
Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks
J. Pharm. Biomed. Anal.
(2012) - et al.
A rapid, quantitative liquid chromatography–mass spectrometry screening method for 71 active and 11 natural erectile dysfunction ingredients present in potentially adulterated or counterfeit products
J. Chromatogr. A
(2014) - et al.
Isolation and structural characterization of two tadalafil analogs found in dietary supplements
J. Pharm. Biomed. Anal.
(2012) - et al.
Separation and structural elucidation of a new tadalafil analogue diethylaminopretadalafil included as an adulterant in a dietary supplement
J. Pharm. Biomed. Anal.
(2014)
Cited by (24)
Isolation and characterization of a novel tadalafil analogue adulterant, N-cyclohexyl nortadalafil, in a dietary supplement
2023, Journal of Pharmaceutical and Biomedical AnalysisCombining trapped ion mobility spectrometry with liquid chromatography and tandem mass spectrometry for analysis of isomeric PDE-5 inhibitor analogs
2023, Journal of Pharmaceutical and Biomedical AnalysisCitation Excerpt :Manufacturers of such dietary supplements may attempt to evade detection of the illegal active ingredients and subsequent regulation of their products by using analogs of the PDE-5 inhibitors that have been approved for erectile dysfunction treatment. Many examples of these analogs have been, and continue to be, reported [1,9–12] and it is expected that the synthesis of new analogs will continue as the market for sexual enhancement supplements continues to grow. To date, more than 80 analogs of the approved PDE-5 inhibitors have been analyzed at the FDA Forensic Chemistry Center.
An Analysis of Popular Online Erectile Dysfunction Supplements
2019, Journal of Sexual MedicineA review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements
2018, Journal of Pharmaceutical and Biomedical AnalysisCitation Excerpt :Various solvents were used for 1H NMR spectra recording but the nature of solvent does not in fact influence the chemical shift of H6. Indeed, the H6 δ of cis-tadalafil are 6.13, 6.15 and 6.17 ppm in DMSO-d6 [70], CDCl3 [74] and CD3OD [44] respectively. The only significant change of chemical shift is observed for homotadalafil in pyridine-d5 with a H6 at 6.54 ppm [69].
Reliable screening and confirmation of 156 multi-class illegal adulterants in dietary supplements based on extracted common ion chromatograms by ultra-high-performance liquid chromatography-quadrupole/time of flight-mass spectrometry
2017, Journal of Chromatography ACitation Excerpt :Moreover, a number of drug analogues and newly designed drugs as functional food additives have been developed in order to intentionally avoid their illegal addition in a screening test [3,4]. For example, the erectile dysfunction drugs and their analogues, steroids, and other pharmaceuticals are frequently reported as illegal adulterants in dietary supplements [5,6]. These illegal adulterants are known to possibly cause a variety of adverse effects.